Platelet Count During Course of Cardiogenic Shock.
Journal
ASAIO journal (American Society for Artificial Internal Organs : 1992)
ISSN: 1538-943X
Titre abrégé: ASAIO J
Pays: United States
ID NLM: 9204109
Informations de publication
Date de publication:
16 Oct 2023
16 Oct 2023
Historique:
medline:
13
10
2023
pubmed:
13
10
2023
entrez:
13
10
2023
Statut:
aheadofprint
Résumé
The study investigates the prognostic value of the platelet count in patients with cardiogenic shock (CS). Limited data regarding the prognostic value of platelets in patients suffering from CS is available. Consecutive patients with CS from 2019 to 2021 were included at one institution. Firstly, the prognostic value of the baseline platelet count was tested for 30-day all-cause mortality. Thereafter, the prognostic impact of platelet decline during course of intensive care unit (ICU) hospitalization was assessed. A total of 249 CS patients were included with a median platelet count of 224 × 106/ml. No association of the baseline platelet count with the risk of 30-day all-cause mortality was found (log-rank p = 0.563; hazard ratio [HR] = 0.879; 95% confidence interval [CI] 0.557-1.387; p = 0.579). In contrast, a decrease of platelet count by ≥ 25% from day 1 to day 3 was associated with an increased risk of 30-day all-cause mortality (55% vs. 39%; log-rank p = 0.045; HR = 1.585; 95% CI 0.996-2.521; p = 0.052), which was still evident after multivariable adjustment (HR = 1.951; 95% CI 1.116-3.412; p = 0.019). Platelet decrease during the course of ICU hospitalization but not the baseline platelet count was associated with an increased risk of 30-day all-cause mortality in CS patients.
Identifiants
pubmed: 37831815
doi: 10.1097/MAT.0000000000002066
pii: 00002480-990000000-00328
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
Copyright © ASAIO 2023.
Déclaration de conflit d'intérêts
Disclosure: The authors have no conflicts of interest to report.
Références
Shah AH, Puri R, Kalra A: Management of cardiogenic shock complicating acute myocardial infarction: A review. Clin Cardiol 42: 484–493, 2019.
Siddiqi HK, DeFilippis EM, Biery DW, et al.: Mortality and heart failure hospitalization among young adults with and without cardiogenic shock after acute myocardial infarction. J Card Fail, 2022.
van Diepen S, Katz JN, Albert NM, et al.; American Heart Association Council on Clinical Cardiology; Council on Cardiovascular and Stroke Nursing; Council on Quality of Care and Outcomes Research; and Mission: Lifeline: Contemporary management of cardiogenic shock: a scientific statement from the American Heart Association. Circulation 136: e232–e268, 2017.
Osman M, Syed M, Patibandla S, et al.: Fifteen-year trends in incidence of cardiogenic shock hospitalization and in-hospital mortality in the United States. J Am Heart Assoc 10: e021061, 2021.
Schrage B, Becher PM, Bernhardt A, et al.: Left ventricular unloading is associated with lower mortality in patients with cardiogenic shock treated with venoarterial extracorporeal membrane oxygenation: results from an International, Multicenter Cohort Study. Circulation 142: 2095–2106, 2020.
Rohm CL, Gadidov B, Ray HE, Mannino SF, Prasad R: Vasopressors and inotropes as predictors of mortality in acute severe cardiogenic shock treated with the impella device. Cardiovasc Revasc Med 31: 71–75, 2021.
Muzafarova T, Motovska Z: Laboratory predictors of prognosis in cardiogenic shock complicating acute myocardial infarction. Biomedicines 10: 1328, 2022.
Zhou H, Li Z, Liang H, Yan Z: Thrombocytopenia and platelet count recovery in patients with sepsis-3: a retrospective observational study. Platelets 33: 612–620, 2022.
Claushuis TA, van Vught LA, Scicluna BP, et al.; Molecular Diagnosis and Risk Stratification of Sepsis Consortium: Thrombocytopenia is associated with a dysregulated host response in critically ill sepsis patients. Blood 127: 3062–3072, 2016.
Liu R, Liu J, Yang J, et al.: Association of thrombocytopenia with in-hospital outcome in patients with acute ST-segment elevated myocardial infarction. Platelets 30: 844–853, 2019.
Rubinfeld GD, Smilowitz NR, Berger JS, Newman JD: Association of thrombocytopenia, revascularization, and in-hospital outcomes in patients with acute myocardial infarction. Am J Med 132: 942–948.e5, 2019.
Bennett D, Hodgson ME, Shukla A, Logie JW: Prevalence of diagnosed adult immune thrombocytopenia in the United Kingdom. Adv Ther 28: 1096–1104, 2011.
Lee HH, Hong SJ, Ahn CM, et al.: Clinical implications of thrombocytopenia at cardiogenic shock presentation: data from a Multicenter Registry. Yonsei Med J 61: 851–859, 2020.
Wang L, Yang F, Wang X, et al.: Predicting mortality in patients undergoing VA-ECMO after coronary artery bypass grafting: the REMEMBER score. Crit Care 23: 11, 2019.
Shuster M, Konopka CI, Verlinden NJ: Incidence and timing of thrombocytopenia in patients receiving impella ventricular assist device support. ASAIO J 68: 1135–1140, 2022.
Okadome Y, Morinaga J, Fukami H, et al.: Hyperglycemia and thrombocytopenia - combinatorially increase the risk of mortality in patients with acute myocardial infarction undergoing veno-arterial extracorporeal membrane oxygenation. Circ Rep 3: 707–715, 2021.
Desch S, Freund A, Akin I, et al.; TOMAHAWK Investigators: Angiography after out-of-hospital cardiac arrest without ST-Segment Elevation. N Engl J Med 385: 2544–2553, 2021.
Thiele H, Akin I, Sandri M, et al.; CULPRIT-SHOCK Investigators: PCI strategies in patients with acute myocardial infarction and cardiogenic shock. N Engl J Med 377: 2419–2432, 2017.
Thiele H, Akin I, Sandri M, et al.; CULPRIT-SHOCK Investigators: One-year outcomes after PCI strategies in cardiogenic shock. N Engl J Med 379: 1699–1710, 2018.
Zeymer U, Bueno H, Granger CB, et al.: Acute Cardiovascular Care Association position statement for the diagnosis and treatment of patients with acute myocardial infarction complicated by cardiogenic shock: A document of the Acute Cardiovascular Care Association of the European Society of Cardiology. Eur Heart J Acute Cardiovasc Care 9: 183–197, 2020.
Vranckx P, White HD, Huang Z, et al.: Validation of BARC bleeding criteria in patients with acute coronary syndromes: the TRACER Trial. J Am Coll Cardiol 67: 2135–2144, 2016.
Abdi H: The greenhouse-geisser correction. Encycl Res Des 1: 544–548, 2010.
Roy SK, Howard EW, Panza JA, Cooper HA: Clinical implications of thrombocytopenia among patients undergoing intra-aortic balloon pump counterpulsation in the coronary care unit. Clin Cardiol 33: 30–35, 2010.
González-Pacheco H, Manzur-Sandoval D, Gopar-Nieto R, et al.: Cardiogenic shock among patients with and without acute myocardial infarction in a Latin American country: a Single-Institution Study. Glob Heart 16: 78, 2021.
Ghajar A, Ordonez CP, Philips B, et al.: Cardiogenic shock related cardiovascular disease mortality trends in US population: Heart failure vs. acute myocardial infarction as contributing causes. Int J Cardiol 367: 45–48, 2022.
Harjola VP, Lassus J, Sionis A, et al.: Clinical picture and risk prediction of short-term mortality in cardiogenic shock. Eur J Heart Fail 17: 501–509, 2015.
Pöss J, Köster J, Fuernau G, et al.: Risk stratification for patients in cardiogenic shock after acute myocardial infarction. J Am Coll Cardiol 69: 1913–1920, 2017.
Akca S, Haji-Michael P, de Mendonça A, Suter P, Levi M, Vincent JL: Time course of platelet counts in critically ill patients. Crit Care Med 30: 753–756, 2002.
Schupp T, Weidner K, Rusnak J, et al.: Diagnostic and prognostic role of platelets in patients with sepsis and septic shock. Platelets 34: 2131753, 2023.
Aslam R, Speck ER, Kim M, et al.: Platelet Toll-like receptor expression modulates lipopolysaccharide-induced thrombocytopenia and tumor necrosis factor-alpha production in vivo. Blood 107: 637–641, 2006.
François B, Trimoreau F, Vignon P, Fixe P, Praloran V, Gastinne H: Thrombocytopenia in the sepsis syndrome: role of hemophagocytosis and macrophage colony-stimulating factor. Am J Med 103: 114–120, 1997.
Iba T, Watanabe E, Umemura Y, et al.; Japanese Surviving Sepsis Campaign Guideline Working Group for disseminated intravascular coagulation: Sepsis-associated disseminated intravascular coagulation and its differential diagnoses. J Intensive Care 7: 32, 2019.
Mammen EF, Koets MH, Washington BC, Wolk LW, Brown JM, Burdick M, Selik NR, Wilson RF: Hemostasis changes during cardiopulmonary bypass surgery. In: Seminars in thrombosis and hemostasis: 1985: Copyright© 1985 by Thieme Medical Publishers, Inc.; 1985: 281–292.
Sugimura Y, Bauer S, Immohr MB, et al.: Heparin-induced thrombocytopenia under mechanical circulatory support by large impella for acute cardiogenic shock. J Cardiovasc Dev Dis 8: 161, 2021.
Wang L, Shao J, Shao C, Wang H, Jia M, Hou X: The relative early decrease in platelet count is associated with mortality in post-cardiotomy patients undergoing venoarterial extracorporeal membrane oxygenation. Front Med (Lausanne) 2021: 46, 7339.
Thiele H, Zeymer U, Neumann FJ, et al.; IABP-SHOCK II Trial Investigators: Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med 367: 1287–1296, 2012.
Basir MB, Schreiber T, Dixon S, et al.: Feasibility of early mechanical circulatory support in acute myocardial infarction complicated by cardiogenic shock: The Detroit cardiogenic shock initiative. Catheter Cardiovasc Interv 91: 454–461, 2018.
Chioncel O, Collins SP, Ambrosy AP, et al.: Therapeutic Advances in the Management of Cardiogenic Shock. Am J Ther 26: e234–e247, 2019.
Shah M, Patnaik S, Patel B, et al.: Trends in mechanical circulatory support use and hospital mortality among patients with acute myocardial infarction and non-infarction related cardiogenic shock in the United States. Clin Res Cardiol 107: 287–303, 2018.
Thiele H, Freund A, Gimenez MR, et al.; ECLS-SHOCK Investigators: Extracorporeal life support in patients with acute myocardial infarction complicated by cardiogenic shock - Design and rationale of the ECLS-SHOCK trial. Am Heart J 234: 1–11, 2021.